Korea United Pharm Inc. (033270.KS)
KRW 18480.0
(-1.75%)
KRW 18480.0
(-1.75%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 278.94 Billion | 262.52 Billion | 221.03 Billion | 215.94 Billion | 221.31 Billion | 211.93 Billion |
| Cost of Revenue | 105.45 Billion | 117.23 Billion | 98.38 Billion | 90.75 Billion | 92.72 Billion | 86.45 Billion |
| Gross Profit | 173.48 Billion | 145.28 Billion | 122.65 Billion | 125.19 Billion | 128.58 Billion | 125.47 Billion |
| Operating Expenses | 118.21 Billion | 97.07 Billion | 89.43 Billion | 85.06 Billion | 93.58 Billion | 87.72 Billion |
| Selling, General and Administrative Expenses | 36.75 Billion | 34.68 Billion | 33.81 Billion | 32.9 Billion | 38.88 Billion | 34.98 Billion |
| Research and Development Expenses | 17.3 Billion | 15.53 Billion | 13.79 Billion | 12.26 Billion | 14.09 Billion | 12.44 Billion |
| Other Expenses | 49.96 Billion | 46.85 Billion | 41.82 Billion | 39.88 Billion | 40.6 Billion | 2.76 Billion |
| Cost and Expenses | 223.66 Billion | 214.3 Billion | 187.81 Billion | 175.82 Billion | 186.31 Billion | 174.18 Billion |
| Operating Income | 54.94 Billion | 48.21 Billion | 33.22 Billion | 40.12 Billion | 34.47 Billion | 37.75 Billion |
| Interest Expense | 1.61 Billion | 815.53 Million | 501.91 Million | 575.54 Million | 702.29 Million | 605.38 Million |
| Income Tax Expense | 11.82 Billion | 8.14 Billion | 10.83 Billion | 9.03 Billion | 7.61 Billion | 8.26 Billion |
| Earnings before Tax | 59.06 Billion | 53.42 Billion | 39.48 Billion | 35.65 Billion | 38.53 Billion | 39.93 Billion |
| Net Income | 48.26 Billion | 45.27 Billion | 28.64 Billion | 26.61 Billion | 30.91 Billion | 31.67 Billion |
| Earnings Per Share Basic | 3297.93 | 3057.78 | 1930.09 | 1793.76 | 2086.92 | 2139.20 |
| Earnings Per Share Diluted | 3277.48 | 3038.18 | 1917.77 | 1787.06 | 2086.16 | 2139.00 |
| Weighted Average Shares Outstanding | 14.63 Million | 14.8 Million | 14.84 Million | 14.83 Million | 14.81 Million | 14.8 Million |
| Weighted Average Shares Outstanding (Diluted) | 14.72 Million | 14.9 Million | 14.93 Million | 14.89 Million | 14.81 Million | 14.8 Million |
| Gross Margin | 0.62 | 0.55 | 0.55 | 0.58 | 0.58 | 0.59 |
| EBIT Margin | 0.25 | 0.27 | 0.23 | 0.23 | 0.23 | 0.25 |
| Profit Margin | 0.17 | 0.17 | 0.13 | 0.12 | 0.14 | 0.15 |
| EBITDA | 70.78 Billion | 61.76 Billion | 46.61 Billion | 43.26 Billion | 44.96 Billion | 47.63 Billion |
| Earnings Before Tax Margin | 0.20 | 0.18 | 0.15 | 0.19 | 0.16 | 0.18 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 71.35 Billion | 70.99 Billion | 73.17 Billion | 278.94 Billion | 70.99 Billion | 70.61 Billion |
| Cost of Revenue | - | 25.35 Billion | 27.26 Billion | 105.45 Billion | 29.2 Billion | 29.93 Billion |
| Gross Profit | 71.35 Billion | 45.63 Billion | 45.9 Billion | 173.48 Billion | 41.79 Billion | 40.67 Billion |
| Operating Expenses | 56.3 Billion | 58.46 Billion | 56.3 Billion | 118.21 Billion | 31.06 Billion | -24.66 Billion |
| Selling, General and Administrative Expenses | - | 22.88 Billion | 21.58 Billion | - | 20.66 Billion | 24.66 Billion |
| Research and Development Expenses | - | 8.41 Billion | 7.58 Billion | - | 9.7 Billion | 3.98 Billion |
| Other Expenses | -56.3 Billion | -58.46 Billion | -56.3 Billion | -1.78 Billion | -704.41 Million | -49.32 Billion |
| Cost and Expenses | 56.3 Billion | 58.46 Billion | 56.3 Billion | 223.66 Billion | 60.26 Billion | 29.93 Billion |
| Operating Income | 15.05 Billion | 12.53 Billion | 16.86 Billion | 55.27 Billion | 10.72 Billion | 16.01 Billion |
| Interest Expense | - | 135.84 Million | - | 1.95 Billion | 437.06 Million | 449.11 Million |
| Income Tax Expense | 7.95 Billion | -8.89 Billion | 5.26 Billion | 11.82 Billion | 270.8 Million | 4.48 Billion |
| Earnings before Tax | 13.2 Billion | -15.27 Billion | 24.45 Billion | 59.06 Billion | 2.4 Billion | 21.33 Billion |
| Net Income | 5.25 Billion | -6.38 Billion | 19.18 Billion | 48.26 Billion | 2.59 Billion | 16.84 Billion |
| Earnings Per Share Basic | 323.30 | -436.38 | 1311.13 | - | 177.13 | 1152.35 |
| Earnings Per Share Diluted | 323.30 | -433.68 | 1303.00 | - | 176.96 | 1152.35 |
| Weighted Average Shares Outstanding | 16.24 Million | 14.63 Million | 14.63 Million | 14.63 Million | 14.62 Million | 14.62 Million |
| Weighted Average Shares Outstanding (Diluted) | 16.24 Million | 14.72 Million | 14.72 Million | 14.72 Million | 14.63 Million | 14.62 Million |
| Gross Margin | 1.00 | 0.64 | 0.63 | 0.62 | 0.59 | 0.58 |
| EBIT Margin | 0.21 | 0.18 | 0.23 | - | 0.20 | 0.58 |
| Profit Margin | 0.07 | -0.09 | 0.26 | 0.17 | 0.04 | 0.24 |
| EBITDA | 15.05 Billion | 12.53 Billion | 16.86 Billion | - | 13.89 Billion | 40.67 Billion |
| Earnings Before Tax Margin | 0.21 | 0.18 | 0.23 | 0.20 | 0.15 | 0.23 |
GFAIW
BRE2
AGSVF
FTE
PATINTLOG
9524